Skip to search formSkip to main contentSkip to account menu

1 ML evolocumab 140 MG/ML Prefilled Syringe [Repatha]

Known as: 1 ML Repatha 140 MG/ML Prefilled Syringe, EVOLOCUMAB 140 mg in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [REPATHA], Repatha 140 MG in 1 ML Prefilled Syringe 
National Institutes of Health

Related topics

Related topics

9 relations
1 ML evolocumab 140 MG/ML Auto-Injector [Repatha]ACETATE IONPolysorbate 80Prefilled Syringe

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Emerging role of proprotein convertase subtilisin/kexin type‐9 (PCSK‐9) in inflammation and diseases
2016
2016
Evolocumab (Repatha®): hipercolesterolemia primaria y dislipemia mixta
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)